CN103157035A - Traditional Chinese medicine composition for treating chronic superficial gastritis - Google Patents

Traditional Chinese medicine composition for treating chronic superficial gastritis Download PDF

Info

Publication number
CN103157035A
CN103157035A CN2011104213770A CN201110421377A CN103157035A CN 103157035 A CN103157035 A CN 103157035A CN 2011104213770 A CN2011104213770 A CN 2011104213770A CN 201110421377 A CN201110421377 A CN 201110421377A CN 103157035 A CN103157035 A CN 103157035A
Authority
CN
China
Prior art keywords
radix
chinese medicine
medicine composition
superficial gastritis
chronic superficial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011104213770A
Other languages
Chinese (zh)
Inventor
韩兴霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011104213770A priority Critical patent/CN103157035A/en
Publication of CN103157035A publication Critical patent/CN103157035A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the field of medicine, especially to a traditional Chinese medicine composition for treating chronic superficial gastritis. Bulk drugs for the composition comprise, by weight, 25 to 35 g of milkvetch root, 4 to 6 g of licorice, 12 to 18 g of ginseng, 12 to 18 g of Chinese angelica, 12 to 18 g of red sage root, 15 to 25 g of inner membrane of chicken gizzard, 15 to 20 g of coix seed, 8 to 12 g of orange fruit, 15 to 20 g of glossy privet fruit, 12 to 18 g of largetrifoliolious bugbane rhizome, 12 to 18 g of bighead atractylodes rhizome, 8 to 12 g of shaved cinnamon bark, 5 to 7 g of Chinese herbaceous peony, 8 to 12 g of Chinese date, 8 to 12 g of wolfberry, 15 to 25 g of figwortflower picrorhiza rhizome and 12 to 18 g of rhizome of nutgrass flatsedge. The above-mentioned bulk drugs are weighed in proportion and crushed into 300-mesh fine powder; each 100 g of medicinal powder is added into 300 ml of water for decoction so as to prepare concentrated cream; granules are prepared from the cream by using a granulator, each granule being about 0.1 to 0.15 g, and the granules are dried. The invention has the following beneficial effects: components of the traditional Chinese medicine composition are mutually cooperative; the composition has effects in managing Qi, activating blood, removing blood stasis, relieving pain, strengthening spleen and stomach, soothing liver and intestines, eliminating dampness heat, dispelling turbidity and eliminating inflammation, can enhance human immunity and effectively achieves the purpose of treating chronic superficial gastritis.

Description

A kind of Chinese medicine composition for the treatment of chronic superficial gastritis
Technical field
The present invention relates to field of medicaments, particularly a kind of Chinese medicine composition for the treatment of chronic superficial gastritis.
Background technology
Chronic atrophic gastritis is to be developed by chronic superficial gastritis.The cause of disease of chronic superficial gastritis all can become causing a disease and Acute aggravated factors of chronic atrophic gastritis.After sphincter of pylorus functional disorder or gastrojejunostomy, bile or duodenal juice can instead flow to gastric, and destruction gastric mucosal barrier, impel counter being dissipated to of H+ and pepsin to cause a series of pathological changes in mucosa, thereby cause chronic superficial gastritis, and can develop into chronic atrophic gastritis.Chronic infectious disease such as hepatitis, tuberculosis etc. have also caused people's attention on the impact of stomach.Chronic hepatitis patients often has the sings and symptoms of chronic gastritis, and gastric mucosa dyeing also confirms to have the antigen antibody complex of hepatitis B virus in hepatitis B patient gastric mucosa.Radiotherapy Peptic Ulcers or other tumors can make even atrophy of gastric mucosa injury.A lot of statement of facts iron deficiency anemias are in close relations with atrophic gastritis, and some scholar thinks that gastritis is protopathy, cause ferrum and can not absorb because gastritis gastric acid is low, or consequently form anemia because of gastrorrhagia; Another kind of suggestion thinks that anemia is first arranged, because in health, iron deficiency makes the gastric mucosa turnover rate influenced and easily be inflamed.From the morbidity state to the therapeutic effect, the development of novel drugs is imperative.
Summary of the invention
The object of the invention is to provide a kind of Chinese medicine composition for the treatment of chronic superficial gastritis, and its expense is low, easily take, good effect.
A kind of Chinese medicine composition for the treatment of chronic superficial gastritis, its crude drug by following parts by weight forms: Radix Astragali 25-35g, Radix Glycyrrhizae 4-6g, Radix Ginseng 12-18g, Radix Angelicae Sinensis 12-18g, Radix Salviae Miltiorrhizae 12-18g, Endothelium Corneum Gigeriae Galli 15-25g, Semen Coicis 15-20g, Fructus Aurantii 8-12g, Fructus Ligustri Lucidi 15-20, Rhizoma Cimicifugae 12-18g, Rhizoma Atractylodis Macrocephalae 12-18g, Cortex Cinnamomi 8-12g, Radix Paeoniae 5-7g, Fructus Jujubae 8-12g, Fructus Lycii 8-12g, Rhizoma Picrorhizae 15-25g and Rhizoma Cyperi 12-18g.With the above-mentioned raw materials medicine through being ground into fine powder or making pill with conventional method and take.
Chinese medicine composition low cost of manufacture of the present invention has the clinical trial experience, easily takes, and successful, cure rate is high.
The specific embodiment
Below in conjunction with practical situation, the present invention is elaborated.
Embodiment 1,
Take: Radix Astragali 25g, Radix Glycyrrhizae 4g, Radix Ginseng 12g, Radix Angelicae Sinensis (processed with wine) 12g, Radix Salviae Miltiorrhizae 12g, Endothelium Corneum Gigeriae Galli 15g, Semen Coicis 20g, Fructus Aurantii 12g, Fructus Ligustri Lucidi 10g, Rhizoma Cimicifugae 12g, Rhizoma Atractylodis Macrocephalae 12g, Cortex Cinnamomi 8g, Radix Paeoniae 5g, Fructus Jujubae (pitted) 8g, Fructus Lycii 12g, processed with wine Rhizoma Picrorhizae 15g and Rhizoma Cyperi 12g form, and are ground into 300 order fine powders or make Chinese medicine pill;
Embodiment 2,
Take: Radix Astragali 30g, Radix Glycyrrhizae 5g, Radix Ginseng 15g, Radix Angelicae Sinensis (processed with wine) 15g, Radix Salviae Miltiorrhizae 15g, Endothelium Corneum Gigeriae Galli 20g, Semen Coicis 18g, Fructus Aurantii 10g, Fructus Ligustri Lucidi g, Rhizoma Cimicifugae 15g, Rhizoma Atractylodis Macrocephalae 15g, Cortex Cinnamomi 10g, Radix Paeoniae 6g, Fructus Lycii 8g, Fructus Jujubae (pitted) 10g, processed with wine Rhizoma Picrorhizae 20g and Rhizoma Cyperi 15g form, and are ground into 300 order fine powders or make Chinese medicine pill;
Embodiment 3,
Take: Radix Astragali 35g, Radix Glycyrrhizae 6g, Radix Ginseng 18g, Radix Angelicae Sinensis (processed with wine) 18g, Radix Salviae Miltiorrhizae 18g, Endothelium Corneum Gigeriae Galli 25g, Semen Coicis 15g, Fructus Aurantii 8g, Fructus Ligustri Lucidi 15, Fructus Lycii 12g, Rhizoma Cimicifugae 18g, Rhizoma Atractylodis Macrocephalae 18g, Cortex Cinnamomi 12g, Radix Paeoniae 6g, Fructus Jujubae (pitted) 12g, processed with wine Rhizoma Picrorhizae 25g and Rhizoma Cyperi 18g form, and are ground into 300 order fine powders or make Chinese medicine pill;
The Chinese medicine pill of making of the present invention is by said components and proportioning, is ground into 300 order fine powders, and every 100g medicated powder adds the decocting of 300ml to make condensed cream, by the granulator corning, and dry getting final product, every about 0.1-0.15g.
A kind of Chinese medicine composition for the treatment of chronic superficial gastritis of the present invention, the drug action of its crude drug is:
The Radix Astragali: qi-supplementing, blood-engendering, consolidating superficial resistance evacuation of pus;
Radix Glycyrrhizae: invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, coordinating the actions of various ingredients in a prescription;
Fructus Jujubae (pitted): spleen reinforcing stomach function regulating, supplementing QI for promoting the production of body fluid;
Radix Ginseng: strongly invigorating primordial QI, spleen reinforcing is promoted the production of body fluid, the mind calming and mentality promoting;
Radix Angelicae Sinensis (processed with wine): use the wine parch, become Radix Angelicae Sinensis (processed with wine), benefiting blood and regulating blood circulation is arranged, menstruction regulating and pain relieving, the effect of loosening bowel to relieve constipation;
Radix Salviae Miltiorrhizae: promoting blood flow to regulate menstruation, removing blood stasis and cleaning heat;
Endothelium Corneum Gigeriae Galli: removing food stagnancy relieving dyspepsia;
Semen Coicis: the effects such as inducing diuresis to remove edema, spleen invigorating are dried, arthralgia relieving by relaxing muscles and tendons, clearing away heat and discharging pus are arranged;
Fructus Aurantii: regulating the flow of QI to ease the stomach, the stagnant relieving distension of row.
Fructus Ligustri Lucidi: liver and kidney tonifying; Clearind deficient heat;
Fructus Lycii: the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity, blood-enriching tranquillizing, promoting the production of body fluid to quench thirst, nourishing the lung to arrest cough.
Rhizoma Cimicifugae: deliver the rash detoxifcation, elevate a turnable ladder yang-energy function;
The Rhizoma Atractylodis Macrocephalae: invigorating the spleen and replenishing QI, dampness diuretic, strengthening superficial resistance to stop perspiration;
Cortex Cinnamomi: the YANG invigorating blood circulation-promoting functions is arranged;
Radix Paeoniae: arranged, Radix Paeoniae Rubra blood circulation promoting and blood stasis dispelling, dispersing swelling and dissipating binds dividing of Radix Paeoniae Rubra, the Radix Paeoniae Alba; Radix Paeoniae Alba easing the affected liver to relieve pain nourishes blood and holds back sun, suppressing liver-YANG; All can with Radix Paeoniae Rubra or the Radix Paeoniae Alba or its mixing in the present invention;
Processed with wine Rhizoma Picrorhizae: become the processed with wine Rhizoma Picrorhizae with the wine parch, clearing away damp-heat is arranged, move back hectic fever due to YIN-deficiency, the effect of the infantile malnutrition that disappears;
Rhizoma Cyperi: the resolving depression of regulating the flow of vital energy, menstruction regulating and pain relieving.
Effective combination of said medicine is coordinated mutually, vital energy regualting and blood circulation-promoting, and clear stasis of blood pain relieving, strengthening the spleen and stomach, the soothing liver-QI intestinal, row is turbid for clearing away damp-heat, and antiinflammatory strengthens immune function of human body, effectively reaches treatment chronic superficial gastritis purpose, and is the clinical data sufficient proof, and interrelated data is as follows:
One, select the case standard
All stomachaches, suffer from diarrhoea, be off one's feed, have an X-rayed the ulcer surface patient and all can be used as the standard of selecting case.
Two, diagnostic criteria
Press National Diagnostic Criteria and carry out, above-mentioned (one) symptom is arranged, and make a definite diagnosis through gastroscope, CT examination or enteroscopy.
Three, therapeutic scheme
Can take Chinese medicine of the present invention according to the different patient's condition, take by dissimilar plus-minus, per day for adults 2 times, each 20-30 grain (ball), every 0.1-0.15g, 20-30 grain are 2-3g, take 1 hour ante cibum, the child is cut down according to the circumstance, and every 10 days is a course for the treatment of, can take continuously, after two courses for the treatment of, the statistics curative effect.And establish matched group and compare, matched group is with conventional gastroenteritis medicine stomach function regulating ball.
Four, efficacy assessment standard is pressed the execution of national health ministerial standard.
Cure: inflammation all disappears, and the ulcer surface healing recovers normal fully, and is confirmed by CT or intestinal, gastroscopy;
Effectively: symptom is improved in varying degrees or takes a turn for the better, and needs to continue the medication treatment;
Invalid: symptom is without any improvement or take a turn for the better, and the trend of development is even arranged.
Five, statistical disposition
Through 358 people are taken Chinese medicine of the present invention, gastroenteropathy patient 258 people wherein, ulcer patient 100 people, statistical result such as following table:
Type Number of cases Cure Effectively Invalid Total effective rate
Superficial gastritis 260 people 254 people 4 people 2 people 99.3%
Type Number of cases Cure Effectively Invalid Total effective rate
Intestine gastric ulcer 100 people 58 people 41 people 1 people 99%
Matched group 20 people, take existing Chinese medicine stomach invigorating stomach function regulating ball statistical result and be: only have 5 people to cure 1-3 the course for the treatment of, and 10 people have to a certain degree improvement (effectively), invalid 5 people, effective percentage 75%, this is far below Chinese medicine of the present invention.
Six, conclusion
From this, Chinese medicine of the present invention is evident in efficacy to the treatment chronic superficial gastritis, and intestine gastric ulcer is also had good effect, and on probation, without any untoward reaction, safety has no side effect, and effective percentage is up to 99%.

Claims (2)

1. Chinese medicine composition for the treatment of chronic superficial gastritis, it is characterized in that being formed by the crude drug of following parts by weight: Radix Astragali 25-35g, Radix Glycyrrhizae 4-6g, Radix Ginseng 12-18g, Radix Angelicae Sinensis 12-18g, Radix Salviae Miltiorrhizae 12-18g, Endothelium Corneum Gigeriae Galli 15-25g, Semen Coicis 15-20g, Fructus Aurantii 8-12g, Fructus Ligustri Lucidi 15-20, Rhizoma Cimicifugae 12-18g, Rhizoma Atractylodis Macrocephalae 12-18g, Cortex Cinnamomi 8-12g, Radix Paeoniae 5-7g, Fructus Jujubae 8-12g, Fructus Lycii 8-12g, Rhizoma Picrorhizae 15-25g and Rhizoma Cyperi 12-18g.
2. a kind of Chinese medicine composition for the treatment of chronic superficial gastritis as claimed in claim 1; its preparation method is: by above-mentioned prescription proportioning weighting raw materials; be ground into 300 order fine powders; every 100g medicated powder adds the decocting of 300ml to make condensed cream; by the granulator corning; dry getting final product, every about 0.1-0.15g.
CN2011104213770A 2011-12-14 2011-12-14 Traditional Chinese medicine composition for treating chronic superficial gastritis Pending CN103157035A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011104213770A CN103157035A (en) 2011-12-14 2011-12-14 Traditional Chinese medicine composition for treating chronic superficial gastritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011104213770A CN103157035A (en) 2011-12-14 2011-12-14 Traditional Chinese medicine composition for treating chronic superficial gastritis

Publications (1)

Publication Number Publication Date
CN103157035A true CN103157035A (en) 2013-06-19

Family

ID=48580900

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011104213770A Pending CN103157035A (en) 2011-12-14 2011-12-14 Traditional Chinese medicine composition for treating chronic superficial gastritis

Country Status (1)

Country Link
CN (1) CN103157035A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103550690A (en) * 2013-10-26 2014-02-05 荣成市科学技术情报研究所 Traditional Chinese medicine composition for treating superficial gastritis
CN103721219A (en) * 2013-11-20 2014-04-16 邢怀强 Traditional Chinese medicine composition for treating chronic gastropathy
CN104013763A (en) * 2014-06-30 2014-09-03 曹健 Traditional Chinese medicine preparation for treating chronic enterogastritis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101185717A (en) * 2007-12-19 2008-05-28 吴作敬 Traditional Chinese medicine for treating acute chronic gastroenteritis and intestine gastric ulcer
KR20110056909A (en) * 2009-11-23 2011-05-31 주식회사 티제이네츄럴 Composition of mixed herb medicine for chicken boiled with rice and milk vetch root

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101185717A (en) * 2007-12-19 2008-05-28 吴作敬 Traditional Chinese medicine for treating acute chronic gastroenteritis and intestine gastric ulcer
KR20110056909A (en) * 2009-11-23 2011-05-31 주식회사 티제이네츄럴 Composition of mixed herb medicine for chicken boiled with rice and milk vetch root

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103550690A (en) * 2013-10-26 2014-02-05 荣成市科学技术情报研究所 Traditional Chinese medicine composition for treating superficial gastritis
CN103721219A (en) * 2013-11-20 2014-04-16 邢怀强 Traditional Chinese medicine composition for treating chronic gastropathy
CN103721219B (en) * 2013-11-20 2016-06-29 邢怀强 A kind of Chinese medicine composition treating chronic gastropathy
CN104013763A (en) * 2014-06-30 2014-09-03 曹健 Traditional Chinese medicine preparation for treating chronic enterogastritis

Similar Documents

Publication Publication Date Title
CN101185717B (en) Traditional Chinese medicine for treating acute chronic gastroenteritis and intestine gastric ulcer
CN102727832B (en) Chinese medicinal preparation for treating breast diseases and uterine fibroid and preparation method thereof
CN100518807C (en) A Medicine for treatment of ascites due to cirrhosis
CN103705843A (en) Medicine for treating stomach diseases
CN101181568B (en) Traditional chinese medicine preparation for curing osteoproliferation as well as arthrosis ache
CN102274378B (en) Brain-strengthening and thrombosis-resisting pills for treating cerebrovascular diseases and preparation method thereof
CN101485803B (en) Chinese medicinal composition for treating menoxenia and dysmenorrhea
CN103386074B (en) Traditional Chinese medicinal composition for treating infantile diarrhea and preparation method thereof
CN102727779B (en) Pharmaceutical composition for treating ovarian cysts and preparation method thereof
CN103157035A (en) Traditional Chinese medicine composition for treating chronic superficial gastritis
CN102698207A (en) Traditional Chinese medicine composition for treating hepatopathy and preparation method thereof
CN102784332B (en) Medicine for treating angiitis
CN101579503B (en) Traditional Chinese medicine for treating rheumatism
CN108543044B (en) Combined medicine for treating acne and application thereof
CN102988942A (en) Chinese medicament for treating child anorexia
CN103610982B (en) A kind of medicine for the treatment of rheumatic arthritis
CN102861189A (en) Traditional Chinese medicine composition for treating viral encephalitis
CN102114163A (en) Traditional Chinese medicine for treating Henoch-Schonlein purpura nephritis
CN103223139A (en) Traditional Chinese medicinal composition for treating chronic ulcerative colitis
CN103566241A (en) Traditional Chinese medicinal composition for treating diarrhea
CN102626506B (en) Traditional Chinese medicine for curing seroperitoneum
CN102038926A (en) Traditional Chinese medicine preparation for treating dysmenorrhea
CN106166252A (en) A kind of Chinese medicine formula of urinary system tumor
CN106266968A (en) Herba Artemisiae Scopariae liver heat removing choleretic granules and its preparation method and application
CN104706794A (en) Traditional Chinese medicine formula for treating leukemia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20130619

RJ01 Rejection of invention patent application after publication